Novo Nordisk, the company that has equipped South Africa with human insulin in pens for a decade, opted not to renew its deal, which expired previous month. No other organization has bid within the contract — to https://haseebsesr502162.blogvivi.com/28433260/ozempic-new-me-an-overview